150 related articles for article (PubMed ID: 36966142)
1. Targeted DNA demethylation of the ZNF334 promoter inhibits colorectal cancer growth.
Yang B; Tang H; Wang N; Gu J; Wang Q
Cell Death Dis; 2023 Mar; 14(3):210. PubMed ID: 36966142
[TBL] [Abstract][Full Text] [Related]
2. Targeted demethylation of the SLC5A7 promotor inhibits colorectal cancer progression.
Li Y; Liu B; Yin X; Jiang Z; Fang C; Chen N; Zhang B; Dai L; Yin Y
Clin Epigenetics; 2022 Jul; 14(1):92. PubMed ID: 35858918
[TBL] [Abstract][Full Text] [Related]
3. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2.
Li M; Tang Y; Li Q; Xiao M; Yang Y; Wang Y
Oncogene; 2019 May; 38(18):3488-3503. PubMed ID: 30651599
[TBL] [Abstract][Full Text] [Related]
4. Association of TET1 expression with colorectal cancer progression.
Tian Y; Pan F; Sun X; Gan M; Lin A; Zhang D; Zhu Y; Lai M
Scand J Gastroenterol; 2017 Mar; 52(3):312-320. PubMed ID: 27846738
[TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334.
Sun D; Gan X; Liu L; Yang Y; Ding D; Li W; Jiang J; Ding W; Zhao L; Hou G; Yu J; Wang J; Yang F; Yuan S; Zhou W
Cell Death Dis; 2022 May; 13(5):446. PubMed ID: 35534462
[TBL] [Abstract][Full Text] [Related]
6. Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer.
Cheng YW; Chou CJ; Yang PM
Surg Oncol; 2018 Mar; 27(1):76-81. PubMed ID: 29549908
[TBL] [Abstract][Full Text] [Related]
7. Targeted demethylation of the SARI promotor impairs colon tumour growth.
Wang Q; Dai L; Wang Y; Deng J; Lin Y; Wang Q; Fang C; Ma Z; Wang H; Shi G; Cheng L; Liu Y; Chen S; Li J; Dong Z; Su X; Yang L; Zhang S; Jiang M; Huang M; Yang Y; Yu D; Zhou Z; Wei Y; Deng H
Cancer Lett; 2019 Apr; 448():132-143. PubMed ID: 30771439
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
Choudhury SR; Cui Y; Lubecka K; Stefanska B; Irudayaraj J
Oncotarget; 2016 Jul; 7(29):46545-46556. PubMed ID: 27356740
[TBL] [Abstract][Full Text] [Related]
9. Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis.
Liao CG; Liang XH; Ke Y; Yao L; Liu M; Liu ZK; He L; Guo YX; Bian H; Chen ZN; Kong LM
Oncogene; 2022 Mar; 41(12):1780-1794. PubMed ID: 35132181
[TBL] [Abstract][Full Text] [Related]
10. Disruption of ZNF334 promotes triple-negative breast carcinoma malignancy through the SFRP1/ Wnt/β-catenin signaling axis.
Cheng Z; Yu R; Li L; Mu J; Gong Y; Wu F; Liu Y; Zhou X; Zeng X; Wu Y; Sun R; Xiang T
Cell Mol Life Sci; 2022 May; 79(5):280. PubMed ID: 35507080
[TBL] [Abstract][Full Text] [Related]
11. Targeted DNA demethylation of the
Gallego-Bartolomé J; Gardiner J; Liu W; Papikian A; Ghoshal B; Kuo HY; Zhao JM; Segal DJ; Jacobsen SE
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):E2125-E2134. PubMed ID: 29444862
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer.
Dong Z; Dai L; Zhang Y; Fang C; Shi G; Chen Y; Li J; Wang Q; Fu J; Yu Y; Wang W; Cheng L; Liu Y; Lin Y; Wang Y; Wang Q; Wang H; Zhang H; Zhang Y; Su X; Zhang S; Wang F; Qiu M; Zhou Z; Deng H
PLoS Genet; 2020 Nov; 16(11):e1009159. PubMed ID: 33175846
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of RSPO3 via targeted promoter DNA demethylation inhibits the progression of cholangiocarcinoma.
Wu G; Wang D; Xiong F; Liu W; Wang Q; Chen J; Wang B; Chen Y
Clin Epigenetics; 2023 Nov; 15(1):177. PubMed ID: 37932819
[TBL] [Abstract][Full Text] [Related]
14. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways.
Liu X; Chen X; Zeng K; Xu M; He B; Pan Y; Sun H; Pan B; Xu X; Xu T; Hu X; Wang S
Cell Death Dis; 2018 Oct; 9(10):1037. PubMed ID: 30305607
[TBL] [Abstract][Full Text] [Related]
15. TET-mediated DNA demethylation plays an important role in arsenic-induced HBE cells oxidative stress via regulating promoter methylation of OGG1 and GSTP1.
Wang Q; Wang W; Zhang A
Toxicol In Vitro; 2021 Apr; 72():105075. PubMed ID: 33388378
[TBL] [Abstract][Full Text] [Related]
16. Zinc-finger protein 545 is inactivated due to promoter methylation and functions as a tumor suppressor through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in colorectal cancer.
Xiang S; Xiang T; Xiao Q; Li Y; Shao B; Luo T
Int J Oncol; 2017 Sep; 51(3):801-811. PubMed ID: 28677721
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
Shao K; Pu W; Zhang J; Guo S; Qian F; Glurich I; Jin Q; Ma Y; Ju S; Zhang Z; Ding W
Clin Epigenetics; 2021 Apr; 13(1):89. PubMed ID: 33892791
[TBL] [Abstract][Full Text] [Related]
18. miR-646/TET1 mediated demethylation of IRX1 promoter upregulates HIST2H2BE and promotes the progression of invasive ductal carcinoma.
He B; Chen J; Song W; Bai Y
Genomics; 2021 May; 113(3):1469-1481. PubMed ID: 33667646
[TBL] [Abstract][Full Text] [Related]
19. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
20. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
Neri F; Dettori D; Incarnato D; Krepelova A; Rapelli S; Maldotti M; Parlato C; Paliogiannis P; Oliviero S
Oncogene; 2015 Aug; 34(32):4168-76. PubMed ID: 25362856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
